<?xml version="1.0"?>
 <template xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="openEHR/v1/Template">
   <id>6fb1dc3b-f64c-4189-88c6-1afa8e109585</id>
   <name>Hip Fracture Other Medications Postprocedure Smart Group</name>
   <description>
     <lifecycle_state>Initial</lifecycle_state>
     <details>
       <purpose/>
       <use/>
       <misuse/>
     </details>
     <other_details>
       <item>
         <key>MetaDataSet:Sample Set </key>
         <value>Template metadata sample set </value>
       </item>
       <item>
         <key>Acknowledgements</key>
         <value/>
       </item>
       <item>
         <key>Business Process Level</key>
         <value/>
       </item>
       <item>
         <key>Care setting</key>
         <value/>
       </item>
       <item>
         <key>Client group</key>
         <value/>
       </item>
       <item>
         <key>Clinical Record Element</key>
         <value/>
       </item>
       <item>
         <key>Copyright</key>
         <value/>
       </item>
       <item>
         <key>Issues</key>
         <value/>
       </item>
       <item>
         <key>Owner</key>
         <value/>
       </item>
       <item>
         <key>Sign off</key>
         <value/>
       </item>
       <item>
         <key>Speciality</key>
         <value/>
       </item>
       <item>
         <key>User roles</key>
         <value/>
       </item>
     </other_details>
   </description>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance&apos;]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&lt;em&gt;Contraindications: esophageal stricture or impaired swallowing, Creatinine Clearance less than 35 mL/Min. If patient has previously received zolendronic acid in the past year, or Prolia in the past 6 months&lt;/em&gt;&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;alendronate Tablet&apos;]/activities[at0001]">
     <items>
       <item>
         <key>CKT.Content Details</key>
         <value>&lt;p&gt;70 mg Oral, weekly at least 30 minutes before breakfast. Start on POD 7. Patient to remain upright for at least 30 minutes after medication given&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.clinical_guidance.v1 and name/value=&apos;Clinical Guidance #1&apos;]">
     <items>
       <item>
         <key>CKT.Clinical Guidance</key>
         <value>&lt;p&gt;&lt;em&gt;Contraindications: esophageal stricture or impaired swallowing, Creatinine Clearance less than 30 ml/Min&lt;/em&gt;&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-SECTION.adhoc.v1]/items[openEHR-EHR-INSTRUCTION.service_request.v1 and name/value=&apos;risedronate Tablet&apos;]/activities[at0001]">
     <items>
       <item>
         <key>CKT.Content Details</key>
         <value>&lt;p&gt;35 mg Oral, weekly, at least 30 minutes before breakfast. Start on POD 7. Patient to remain upright for at least 30 minutes after medication given&lt;/p&gt;</value>
       </item>
     </items>
   </annotations>
   <annotations path="[openEHR-EHR-SECTION.adhoc.v1]"><items><item><key>Technical.ï»© Technical Traceability</key><value>{~AHSID~6fb1dc3b-f64c-4189-88c6-1afa8e109585~NAME~Hip Fracture Other Medications Postprocedure Smart Group}</value></item></items></annotations><definition xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" name="Hip Fracture Other Medications Postprocedure Smart Group">
     <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.adhoc.v1" concept_name="Ad hoc heading" max="1" path="/items" name="Bone Resoption Inhibitors (for patients with osteoporosis)">
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" path="/items"/>
       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="02251aaf-ab5e-4304-ae7a-1dd5d69197d8" concept_name="PHARM alendronate Tablet Order" max="1" path="/items" name="alendronate Tablet"/>
       <Item xsi:type="SECTION" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1" concept_name="Clinical Guidance" max="1" path="/items" name="Clinical Guidance #1"/>
       <Item xsi:type="INSTRUCTION" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1" template_id="9849dcde-4921-4aa7-a5fa-adee30bc04ad" concept_name="PHARM risedronate Tablet Order" max="1" path="/items" name="risedronate Tablet"/>
     </Item>
   </definition>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.adhoc.v1">
     <digest id="MD5-CAM-1.0.1">8AE70853975A75254E6D39A8DE3652AF</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-SECTION.clinical_guidance.v1">
     <digest id="MD5-CAM-1.0.1">4B2F0F6CD593E442DA9C30277A3EA9CF</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-INSTRUCTION.service_request.v1">
     <digest id="MD5-CAM-1.0.1">AD8DFB192E67715F0D9E11E95E674AD0</digest>
   </integrity_checks>
   <integrity_checks xsi:type="ArchetypeIntegrity" archetype_id="openEHR-EHR-CLUSTER.service_request_information.v1">
     <digest id="MD5-CAM-1.0.1">230A8D964017E1FD7AC82EBDEE0202A6</digest>
   </integrity_checks>
 </template>